Hartmut Schlüter

Universität Hamburg — Germany

Chemistry · Physical Sciences

48h-index9.5kcitations484works2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Advanced Proteomics Techniques and Applications(74), Mass Spectrometry Techniques and Applications(50), Adenosine and Purinergic Signaling(44), Protein purification and stability(28), Rabies epidemiology and control(27)

Publications484 total

The <i>Legionella</i> phosphocholinase AnkX modulates IMPDH2 regulation and cytoophidia dynamics
2026Open Access
Overexpression of the ERG oncogene in prostate cancer identifies candidates for PARP inhibitor-based radiosensitization
Journal of Clinical Investigation·2026Open Access
Extracellular Vesicle Properties and Functions Are Defined by the Originating Cell's Fitness Status
Journal of Extracellular Biology·2026Open Access
Infrared laser sampling of low volumes combined with shotgun lipidomics reveals lipid markers in palatine tonsil carcinoma
Molecular Oncology·2025Open Access
G-CSF/NAMPT signaling drives neutrophil dysfunction and enhances bacterial infection susceptibility in cancer patients
Nature Communications·2025Open Access
Lipid nanotubes unmask neutrophils for complement attack
Blood·2025Open Access
Top‐Down Proteomics and Proteoforms—The Train Speeds Up!
PROTEOMICS·2025Open Access
The 3rd International Top-Down Proteomics Symposium Brings Proteoform Biology to the Forefront of Proteomics
Journal of the American Society for Mass Spectrometry·2025
OmixLitMiner 2: Guided Literature Mining for Automated Categorization of Marker Candidates in Omics Studies
PROTEOMICS·2025Open Access
Thoracic aortic diseases: Identification of diagnostic biomarkers using proteomic analysis
Cardiovascular Pathology·2025
Supplementary Table S1 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Table S4 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Data from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Figure S1 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Figure S5 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Figure S4 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Methods S2 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Methods S1 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Figure S3 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
Supplementary Table S2 from 6-[(1,4-Naphthoquinone-2-yl)methyl]thio–Glucose Conjugates, a Novel Targeted Approach for Advanced Prostate Cancer
2025Open Access
page 1 of 25Next →

Frequent Co-authors

Walter Zidek(11), Markus van der Giet(10), Martin Tepel(9), Marcel Kwiatkowski(8), Joachim Jankowski(6), Vera Jankowski(5), Thomas Renné(5), Maria Trusch(5), Markus Tölle(4), Jöerg Heeren(4), Marcus Wurlitzer(4), Peter R. Jungblut(3), Klaus Pantel(3), Lars Henning(3), Laura Heikaus(3), Markus Glatzel(3), Christoph Krisp(3), Jeffrey N. Agar(2), Ying Ge(2), Neil L. Kelleher(2)